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ABSTRACT
Background: Despite having the highest disease 
burden of HIV, Sub-Saharan Africa has limited data 
on HIV related kidney disease with most available 
data coming from the developed countries. Kidney 
disease is a recognised complication in HIV infected 
patients presenting with acute renal failure (ARF) or 
chronic kidney disease (CKD). This study 
investigated the prevalence and risk factors 
associated with renal dysfunction among 
hospitalised HIV infected patients at the University 
Teaching Hospital (UTH), Lusaka.
Methodology: We conducted a cross sectional study 
at the University Teaching Hospital Lusaka, in 
Zambia. Inclusion criteria were hospitalised patients 
aged 16years and above who consented to the study. 
Both HIV infected and uninfected patients were 
included in the study. After obtaining demographic 
information, study participants were screened for 
HIV upon their consenting for the test. A full clinical 
history and examination was done by study 
physician to determine factors associated with renal 
dysfunction.
Results: Of the 300 recruited hospitalised patients in 
this cross sectional study, 142(47%) were HIV 
infected. We observed a high prevalence of renal 
dysfunction among hospitalised HIV infected 
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patients compared to uninfected patients (42% vs. 
27%, adjusted OR 1.99, 95% CI 1.20-3.28). They 
had a twofold increased likelihood of developing 
kidney dysfunction (OR 1.96,95 CI%; 1.21-3.17). 
The presence of vomiting was strongly associated 
with renal dysfunction in both HIV positive (AOR 
7.77, 95% CI 2.46-24-53) and negative (AOR4.83, 
95%CI 1.40-16.66) subgroups.  WHO stage III was 
associated with renal dysfunction in HIV infected 
patients. Tenofovir use, (a first line antiretroviral 
drug in Zambia) and hypotension were not 
significant factors associated with kidney disease 
after adjusting for other clinical parameters.
Conclusion: Renal dysfunction is significantly 
higher among hospitalised HIV infected compared 
to uninfected, however tenofovir and hypotension 
were not associated with renal dysfunction. 
INTRODUCTION
Renal disease disproportionately affects patients 
living with HIV. Although Sub-Saharan Africa 
endures over 60% of the world's burden of HIV 
disease, there is limited data in the region on HIV 
related kidney disease, with most available data 
1,2
coming from the developed countries . Kidney 
disease is a recognised complication in HIV infected 
patients whose presentation can be acute renal 
3failure (ARF) or chronic kidney disease (CKD) .
The few outpatient renal screening studies from 
Sub-Saharan Africa describe varying prevalence 
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4 ranging from 6% to almost 50%. A study in Lusaka 
described a prevalence of renal dysfunction of 34% 
among HIV infected outpatients commencing 
5
Highly Active Antiretroviral Treatment (HAART).  
In hospitalised HIV infected patients, prevalence 
may be up to 10 times higher and carries high 
4mortality . This variability can be explained by 
differences in criterion employed in defining kidney 
dysfunction, study designs used and the subject 
population studied. This study investigated the 
prevalence and factors associated with renal 
dysfunction among hospitalised HIV infected and 
uninfected patients.
RESEARCH DESIGN AND METHODS
This was a cross sectional study conducted at the 
University Teaching Hospital, Lusaka, Zambia after 
obtaining approval from the University of Zambia 
Biomedical Ethics Committee. Enrolment of 
participants took place from August, 2010 to 
October, 2010. All consenting hospitalised patients 
at Adult Filter Clinic and Phase V medical admission 
wards were recruited to the study if they were 
admitted to the UTH medical admission wards, were 
aged 16years or older and agreed to participate in the 
study. Recruitment was from Monday to Friday in 
the day time and the first ten eligible patients were 
enrolled to the study per day. 
Using a data collection sheet, information on age, 
race, gender, and marital status was obtained. Study 
participants were screened for HIV after appropriate 
counseling and consent to testing. A full clinical 
history and clinical examination was then performed 
by study physician to assess factors associated with 
renal dysfunction. Blood and urine samples were 
collected to determine renal status. Data collected 
was then transcribed to a data entry programme on 
epi info version 3.5.1.dataset. 
Figure 1:  Participant flow chart
Acute dialysis quality initiative (ADQI) and 
National Kidney Foundation defines ARF using 
RIFLE criteria. 'RIFLE' stands for: Risk is 1.5x 
increases in serum creatinine from normal or GFR 
decrease by 25% or urine output less than 0.5ml/kg 
per hour for 6 hours. Injury is 2 x increases in serum 
creatinine from normal, or GFR decrease by 50% or 
urine output less than 0.5ml/kg per hour for 
12hours.Failure 3 x serum creatinine increases from 
normal or GFR decrease by 75% or urine output less 
than 0.5ml/kg per hour for 24hours. Loss and End 
stage are outcome parameters. CKD is evidence of 
kidney damage that persists for ≥ 3months. Severity 
of damage is graded according to renal function on 
basis of GFR or creatinine clearance into five stages.
For the purpose of this study renal dysfunction was 
defined as rise of serum creatinine 1.5times the 
upper limit of normal, i.e. ≥ 180µmol/l with or 
without decrement in urine output. (Zambia 
Laboratory Services/UTH normal value for 
creatinine is 60-120µmol/l).
Statistical analysis 
Using a prevalence of renal dysfunction of 20% 
among hospitalized HIV infected patients and 8% 
among uninfected patients, sample size was 
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calculated using the Pocock's formula. A minimum 
sample of 141 HIV positive and 141 HIV-negative 
patients was considered adequate to detect a 
difference with an alpha of 0.05. HIV positive and 
uninfected HIV patients were enrolled until there 
were at least 141 in each group. We used frequency 
tables to describe both categorical and quantitative 
variables. Because all continuous variables (other 
than age) had a non-Gaussian distribution, these 
variables were described by median and 
interquartile ranges. Intergroup differences in 
medians of the variables were compared using 
Kruskal-Wallis test for non-parametric variables. 
For categorical variables, frequencies, proportions 
and percentages were used to discuss participants 
and chi-square test was used to assess association 
between the variables. Adjusted odds ratios were 
calculated by multivariable logistic regression in 
order to determine factors independently associated 
with renal dysfunction among HIV infected and 
HIV uninfected patients. A p value of less than 0.05 
was taken as statistically significant.
RESULTS 
Baseline characteristics
Of the 300 hospitalised patients, 154 (51%) were 
males. Ages ranged from 16 to 91 years with mean of 

































































































DBP mean SD 71(19)
 66(13) 75(22) <0.001 
Pulse mean (SD) 95(12) 97(12) 93(12) 0.0038 
Temperature mean (SD) 37(1) 37(1) 37(1) 0.02 
MAP <65mmHg 32(10.7) 21(14.8) 11(7) 0.028 
Nephrotoxic drugs 
 NSAIDs  
 ACEI/ARB  
 Septrin  
Tenofovir  

























Heart failure,  29(9.7) 1(0.7) 28(17.7) <0.001 
CVA,  19(6.3) 2(1.4) 17(10.8) <0.001 
Sepsis,  91(30.3 62(43.7) 29(18.4) <0.001 
Malignancy,  16(5.3) 10(7) 6(3.8) 0.212 
Anemia <8g/dl 102(34) 57(40) 45(28) 0.033 
Creatinine >180 micromole/l 103 (34) 60 (42) 43 (27) 0.006 
* Variables expressed as SD otherwise in % 
Table 1   Baseline characteristics of HIV positive and HIV negative subjects
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The prevalence of renal dysfunction among HIV 
positive subjects was 42% compared to 27% among 
HIV negative participants (AOR 1.99, 95% CI 1.20-
3.28). HIV infected patients were younger than the 
HIV-negative subjects. (35.6 (SD 9.5) vs.44.1 (SD 
20.0), p=0.05). HIV negative patients were 
significantly more likely to have hypertension (22% 
vs.4%, p<0.001)
Heart failure and CVA were common in HIV-
negative patients (p<0.001), while sepsis and 
anemia were more common in HIV infected 
patients. Regarding nephrotoxic drugs,70% of HIV 
reactive patients were taking septrin(used for 
prophylaxis of opportunistic infections) compared 
to only 0.6% of HIV uninfected patients(p<0.001). 
Only 3 of the 300(1%) were using herbal 
medications prior to admission.
Factors associated with renal dysfunction
Of the total 142 HIV positive patients, 2(1.4%) were 
in stage 1, 86(60%) were in stage III and 54(38%) in 
stage IV of HIV infection. The most common stage 
IV conditions were extra pulmonary tuberculosis 
(EPTB) in 18, kaposi's sarcoma in 9 and 
cryptococcal meningitis in 8. Interestingly, WHO 
stage III patients had a higher prevalence of renal 
dysfunction than those with stage IV HIV disease 
(AOR 0.18, 95% CI 0.06-0.53). Of the 61patients on 
HAART, 52 (85.2%) were on tenofovir based 
regimen, 6(9.8%) on AZT (zidovudine) based 
regimen and 3(4.9%) on stavudine based regimen. 
Tenofovir was not associated with renal dysfunction 
among hospitalised patients (1.03; 0.45-2.37, 
95%CI). Other drugs not associated with renal 
dysfunction were amphotericin B (OR 1.49; 0.26-
8.39, 95% CI) and septrin (OR 1.09; 0.49-2.42, 95% 













HTN 2(3.3)  4(4.9)  1.48(0.26-8.39)  
DM 2(3.3)  2(2.4)  1.37(0.19-10.08)  
Diarrhoea  16(26.7)  11(13.4)  2.35(0.99-5.52)  
Vomiting  24(40)  8(9.8)  6.17(2.52-15.08)   
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0.42(0.20-0.86)   
Sepsis 23(38.3)  39(47.6)  0.68(0.34-1.35)  
Malignancy  2(3.3)  8(9.8)  0.32(0.06-1.55)  
MAP < 65  14(23.3)  7(8.5)  3.26(1.22-8.67)   
Anaemia†
 
26(43)  31(37.8)  1.26(0.64-2.47)  
 
Table 2: Factors associated with renal dysfunction among HIV positive participants
†Anaemia defined as Hb < 8 g/dl
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In multivariable analysis, history of vomiting and 
WHO stage III were significant characteristics 
associated with kidney dysfunction among HIV 
positive participants. 
Among uninfected HIV participants, history of 
hypertension and vomiting and use of ACEI were 
significant factors associated with the development 
of kidney dysfunction. Of 54 patients on 
ACE/ARBs, 52(96%) were HIV uninfected patients 
with heart failure. Despite being protective in HIV 
positive patients, only 2(4) HIV infected patients 
were on ACEI/ARB. 
Table 3: Factors associated with renal dysfunction in HIV+ 
multivariable logistic regression
DISCUSSSION
Prevalence of renal dysfunction in our study was 
42% among hospitalised HIV positive infected 
patients compared to 27% among uninfected 
patients.  In a few in-patient studies in Africa, renal 
dysfunction ranged from 17% to almost 30% in HIV 
[4, 9]
positive patients . This is similar to Lopez at al. 
study that found 47% renal dysfunction among 
critically ill hospitalised patients. The subject 
populations in Lopez's study were critically ill and 
hence the slight increase in total number of renal 
[6]dysfunction cases . Franceschini et al. also found 
increased renal dysfunction among hospitalised 
HIV infected in both pre-HAART and post HAART 













































Any HAART  0.49  (0.09-2.55)
 
patients with a threefold increased risk of 
[7, 8, 17developing kidney disease  
Low mean arterial pressure appeared to be a risk 
factor for renal dysfunction but after adjusting for 
other co-variables it was found to be statistically not 
significant unlike previous studies done in Europe 
and Africa. This may be explained by the small 
sample size recruited in our study. In a study by 
Valerie et al. among hospitalized patients, 38% of 
renal dysfunction was due to volume depleting 
conditions. The causes of low mean arterial pressure 
included sepsis with shock, chronic gastroenteritis 
10, 11, 12, 13and adrenal insufficiency . 
WHO stage III was a significant factor associated 
with renal dysfunction in our study unlike previous 
studies that found both stages III and IV as 
5
contributing characteristics . Other studies found 
WHO stage IV renal protective similar to our study 
[5, 18]
findings .This may be explained that patients in 
Zambia delay in seeking treatment.
More patients on tenofovir based regimen had 
kidney disease; however this was not statistically 
significant in our study. This is in keeping with many 
other studies. Izzedine et al study found no 
differences in tenofovir based regimen compared to 
[8, 18]
non-tenofovir based regimen .
Mauss et al. 2005 found renal impairment among 
patients taking tenofovir compared with patients not 
receiving tenofovir. Patients on tenofovir had higher 
proteinuria while their GFR remained the same. 
Cohort and case control studies found that renal 
failure associated with tenofovir was not more 
13, 14, 15common than with other ARV regimens . The 
small sample size of patients on tenofovir in our 
study and criterion used in defining kidney 
dysfunction may also explain the difference.
In our study, a CD4 count below 200 cells was not 
associated with renal dysfunction among 
hospitalised HIV infected patients unlike previous 
studies. In other studies, a low CD4 count was a 
predictor of renal dysfunction and likelihood of 
kidney dysfunction increased with CD4 count <100 
[14,15]cells/mm . Limited sample size of HIV 
hospitalised patients in our study may as well 
explain the difference.
140
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History of hypertension was a significant factor for 
development of renal dysfunction among 
hospitalised HIV uninfected patients similar to other 
[10]studies in Europe and Africa . The likelihood of 
developing renal dysfunction among hypertensive 
patients was almost five fold after adjusting for other 
co-variable. Hypertension is both a cause and 
complication of renal dysfunction and determines 
[16]prognosis . HIV infection was associated with 
reduced prevalence of hypertension in our study 
[19, 21, 22]
similar to other studies  Primary kidney 
disease is responsible for almost 4% hypertension in 
[16, 19, 20]
the general populations .
Vomiting was strongly associated with kidney 
disease in both HIV positive and HIV negative 
patients. Vomiting and nausea are common clinical 
[10]presentations of kidney disease . It is likely that the 
vomiting in our patients was a sign of uremia and not 
a primary cause of kidney dysfunction. Based on our 
findings, renal dysfunction should be suspected in 
any adult patients presenting to the hospital with 
vomiting particularly if the patient is HIV positive.
Our study has several limitations. Cross sectional 
studies by their nature are unable to measure risk nor 
confirm causal relationship among variables. We did 
not have data regarding patient's baseline renal 
function, so we were unable to distinguish between 
acute kidney injury from chronic kidney disease.
CONCLUSION
HIV infection is associated with increased 
prevalence of renal dysfunction in hospitalised 
patients. The presence of vomiting is strongly 
associated with renal dysfunction in HIV positive 
and negative patients. Hypertension and ACE 
inhibitor usage were associated with renal 
dysfunction in uninfected HIV patients.
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